136 related articles for article (PubMed ID: 17950589)
1. Specific reversal of multidrug resistance to colchicine in CEM/VLB(100) cells by Gynostemma pentaphyllum extract.
Huang TH; Bebawy M; Tran VH; Roufogalis BD
Phytomedicine; 2007 Dec; 14(12):830-9. PubMed ID: 17950589
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
[TBL] [Abstract][Full Text] [Related]
3. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
4. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
Shu Y; Liu H
Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
[TBL] [Abstract][Full Text] [Related]
5. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
Holland ML; Panetta JA; Hoskins JM; Bebawy M; Roufogalis BD; Allen JD; Arnold JC
Biochem Pharmacol; 2006 Apr; 71(8):1146-54. PubMed ID: 16458258
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of Annona glabra plant extracts in human leukemia cell lines.
Cochrane CB; Nair PK; Melnick SJ; Resek AP; Ramachandran C
Anticancer Res; 2008; 28(2A):965-71. PubMed ID: 18507043
[TBL] [Abstract][Full Text] [Related]
7. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
Gopinath VS; Thimmaiah P; Thimmaiah KN
Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of Gynostemma pentaphyllum on MCP-1 and type I procollagen expression in rat hepatic stellate cells.
Chen MH; Wang QF; Chen LG; Shee JJ; Chen JC; Chen KY; Chen SH; Su JG; Liu YW
J Ethnopharmacol; 2009 Oct; 126(1):42-9. PubMed ID: 19699789
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
Limtrakul P; Khantamat O; Pintha K
Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
[TBL] [Abstract][Full Text] [Related]
10. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
11. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles.
Bebawy M; Morris MB; Roufogalis BD
Anal Biochem; 1999 Mar; 268(2):270-7. PubMed ID: 10075817
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells.
Zhu H; Liu Z; Tang L; Liu J; Zhou M; Xie F; Wang Z; Wang Y; Shen S; Hu L; Yu L
Eur J Pharmacol; 2012 Dec; 696(1-3):43-53. PubMed ID: 23051672
[TBL] [Abstract][Full Text] [Related]
13. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
14. Phytopreventative effects of Gynostemma pentaphyllum against acute Indomethacin-induced gastrointestinal and renal toxicity in rats.
Hesse C; Razmovski-Naumovski V; Duke CC; Davies NM; Roufogalis BD
Phytother Res; 2007 Jun; 21(6):523-30. PubMed ID: 17380554
[TBL] [Abstract][Full Text] [Related]
15. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
Beck WT; Cirtain MC; Lefko JL
Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
[TBL] [Abstract][Full Text] [Related]
16. Study of sodium orthovanadate as a reverser of multidrug resistance on lymphoblastic leukemic CEM/VLB100 cells.
Colin M; Madoulet C; Baccard N; Arsac F; Jardillier JC
Anticancer Res; 1994; 14(6A):2383-7. PubMed ID: 7825977
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of gypenoside stereoisomers, gypenoside L and gypenoside LI, isolated from Gynostemma pentaphyllum on the growth of human lung cancer A549 cells.
Xing SF; Liu LH; Zu ML; Ding XF; Cui WY; Chang T; Piao XL
J Ethnopharmacol; 2018 Jun; 219():161-172. PubMed ID: 29545210
[TBL] [Abstract][Full Text] [Related]
18. Alterations of vinblastine influx in multidrug-resistant lymphoblastic leukaemic CEM cells.
Colin M; Madoulet C; Warren L; Jardillier JC
Anticancer Res; 1996; 16(1):407-12. PubMed ID: 8615645
[TBL] [Abstract][Full Text] [Related]
19. Phytopreventative anti-hyperlipidemic effects of gynostemma pentaphyllum in rats.
Megalli S; Aktan F; Davies NM; Roufogalis BD
J Pharm Pharm Sci; 2005 Sep; 8(3):507-15. PubMed ID: 16401396
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilatory effects of the aqueous extract of Gynostemma pentaphyllum and gypenosides III and VIII in anaesthetized guinea-pigs.
Circosta C; De Pasquale R; Palumbo DR; Occhiuto F
J Pharm Pharmacol; 2005 Aug; 57(8):1053-8. PubMed ID: 16102262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
